Independent, academic clinical cancer trials are essential to improving patient outcomes, reducing inequalities in care, and strengthening health care systems worldwide, according to a new initiative published in The Lancet Oncology. The paper, “Academic clinical cancer trials to improve patient outcomes,” announces the launch of a Lancet Oncology Commission examining the role, relevance, and challenges of academic clinical cancer research in today’s geopolitical and economic context.
Continue Reading this article here
